| RS121918545 |
TINF2
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal dominant 3 |
| RS121918547 |
AAAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Glucocorticoid deficiency with achalasia, Glucocorticoid deficiency with achalasia |
| RS121918548 |
AAAS
|
Health Risk |
Pathogenic |
Glucocorticoid deficiency with achalasia, Neurodevelopmental disorder |
| RS121918549 |
AAAS
|
Health Risk |
Pathogenic |
Glucocorticoid deficiency with achalasia, AAAS-related disorder |
| RS121918550 |
AAAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Glucocorticoid deficiency with achalasia, Spastic paraparesis |
| RS121918551 |
AAAS
|
Health Risk |
Pathogenic |
Achalasia-alacrima syndrome, Achalasia-alacrima syndrome |
| RS121918552 |
CYCS
|
Health Risk |
Likely pathogenic |
Thrombocytopenia 4, Thrombocytopenia |
| RS121918554 |
SAMD9
|
Health Risk |
Pathogenic |
Normophosphatemic familial tumoral calcinosis, Normophosphatemic familial tumoral calcinosis |
| RS121918555 |
TUBB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Macrothrombocytopenia, isolated |
| RS121918557 |
BCHE
|
Health Risk |
Pathogenic/Likely pathogenic |
Butyrylcholinesterase deficiency, fluoride-resistant |
| RS121918558 |
BCHE
|
Health Risk |
Pathogenic |
Deficiency of butyrylcholinesterase, Deficiency of butyrylcholinesterase |
| RS121918559 |
SFTPC
|
Health Risk |
Pathogenic |
Surfactant metabolism dysfunction, pulmonary |
| RS121918560 |
SFTPC
|
Health Risk |
Pathogenic |
Surfactant metabolism dysfunction, pulmonary |
| RS121918563 |
PRPH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 7, digenic |
| RS121918564 |
PRPH2
|
Health Risk |
Pathogenic |
Vitelliform macular dystrophy 3, PRPH2-related disorder |
| RS121918565 |
PRPH2
|
Health Risk |
Pathogenic |
PRPH2-related disorder, Vitelliform macular dystrophy 3 |
| RS121918566 |
PRPH2
|
Health Risk |
Pathogenic |
Vitelliform macular dystrophy 3, Vitelliform macular dystrophy 3 |
| RS121918567 |
PRPH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Choroidal dystrophy, central areolar 2 |
| RS121918568 |
RAG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined immunodeficiency with skin granulomas, Combined immunodeficiency due to partial RAG1 deficiency |
| RS121918569 |
RAG1
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS121918570 |
RAG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS121918571 |
RAG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Histiocytic medullary reticulosis, Severe combined immunodeficiency |
| RS121918572 |
RAG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe combined immunodeficiency, B cell-negative |
| RS121918573 |
RAG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe combined immunodeficiency, B cell-negative |
| RS121918574 |
RAG2
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency with skin granulomas, Recombinase activating gene 2 deficiency |
| RS121918575 |
RAG2
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Inborn error of immunity |
| RS121918576 |
PDE6A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 43, Retinitis pigmentosa |
| RS121918577 |
PDE6A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 43, Retinal dystrophy |
| RS121918578 |
PDE6A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 43, Retinitis pigmentosa 43 |
| RS121918579 |
PDE6B
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 40, Retinitis pigmentosa |
| RS121918580 |
PDE6B
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 40, Retinitis pigmentosa 40 |
| RS121918581 |
PDE6B
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 40, Retinitis pigmentosa |
| RS121918582 |
PDE6B
|
Health Risk |
Pathogenic |
Congenital stationary night blindness autosomal dominant 2, Congenital stationary night blindness autosomal dominant 2 |
| RS121918583 |
PDE6B
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 40, Autosomal recessive retinitis pigmentosa |
| RS121918584 |
FFAR4;RBP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive retinal dystrophy due to retinol transport defect, Progressive retinal dystrophy due to retinol transport defect |
| RS121918585 |
RBP4;FFAR4
|
Health Risk |
Likely pathogenic |
Progressive retinal dystrophy due to retinol transport defect, Progressive retinal dystrophy due to retinol transport defect |
| RS121918586 |
RHAG
|
Health Risk |
Pathogenic |
Rh mod blood group phenotype, Rh mod blood group phenotype |
| RS121918587 |
RHAG
|
Health Risk |
Likely pathogenic |
Rh-null, regulator type |
| RS121918589 |
RHAG
|
Health Risk |
Pathogenic |
Rh-null, regulator type |
| RS121918590 |
RHO
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 4, Retinitis pigmentosa 4 |
| RS121918591 |
RPIA
|
Health Risk |
Pathogenic |
Deficiency of ribose-5-phosphate isomerase, Deficiency of ribose-5-phosphate isomerase |
| RS121918592 |
RYR1
|
Health Risk |
Pathogenic |
Malignant hyperthermia, susceptibility to |
| RS121918594 |
RYR1
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia, susceptibility to |
| RS121918597 |
RYR2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Cardiomyopathy |
| RS121918598 |
RYR2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS121918599 |
RYR2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS121918600 |
RYR2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Cardiovascular phenotype |
| RS121918601 |
RYR2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS121918602 |
RYR2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia, Long QT syndrome |
| RS121918603 |
RYR2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS121918604 |
RYR2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS121918605 |
RYR2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS121918607 |
AHCY
|
Health Risk |
Pathogenic |
Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase, Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase |
| RS121918608 |
AHCY
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase, Inborn genetic diseases |
| RS121918609 |
STIL
|
Health Risk |
Pathogenic |
Microcephaly 7, primary |
| RS121918610 |
SLC34A1
|
Health Risk |
Pathogenic |
Hypophosphatemic nephrolithiasis/osteoporosis 1, Hypophosphatemic nephrolithiasis/osteoporosis 1 |
| RS121918612 |
ATP1A2
|
Health Risk |
Pathogenic |
Migraine, familial hemiplegic |
| RS121918613 |
ATP1A2
|
Health Risk |
Pathogenic |
Migraine, familial hemiplegic |
| RS121918614 |
ATP1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Migraine, familial hemiplegic |
| RS121918615 |
ATP1A2
|
Health Risk |
Pathogenic |
Migraine, familial hemiplegic |
| RS121918616 |
ATP1A2
|
Health Risk |
Pathogenic |
Migraine, familial basilar |
| RS121918617 |
ATP1A2
|
Health Risk |
Likely pathogenic |
Migraine, familial hemiplegic |
| RS121918620 |
ATP1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Migraine, familial hemiplegic |
| RS121918621 |
SLC5A2
|
Health Risk |
Pathogenic |
Familial renal glucosuria, Familial renal glucosuria |
| RS121918622 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS121918623 |
SCN1A
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS121918624 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Migraine |
| RS121918625 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS121918626 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS121918627 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS121918628 |
SCN1A
|
Health Risk |
Pathogenic |
Migraine, familial hemiplegic |
| RS121918629 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS121918630 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Generalized epilepsy with febrile seizures plus |
| RS121918631 |
SCN1A
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS121918632 |
SCN1A
|
Health Risk |
Pathogenic |
Migraine, familial hemiplegic |
| RS121918633 |
SCN1A
|
Health Risk |
Pathogenic |
Migraine, familial hemiplegic |
| RS121918634 |
SPTA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Elliptocytosis 2, Spherocytosis |
| RS121918636 |
SPTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Elliptocytosis 2, Elliptocytosis 2 |
| RS121918637 |
SPTA1
|
Health Risk |
Pathogenic |
Pyropoikilocytosis, hereditary |
| RS121918638 |
SPTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Elliptocytosis 2, Elliptocytosis 2 |
| RS121918640 |
SPTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Elliptocytosis 2, Elliptocytosis 2 |
| RS121918641 |
SPTA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Elliptocytosis 2, Pyropoikilocytosis |
| RS121918642 |
SPTA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Elliptocytosis 2, Pyropoikilocytosis |
| RS121918643 |
SPTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyropoikilocytosis, hereditary |
| RS121918645 |
SPTB
|
Health Risk |
Likely pathogenic |
Elliptocytosis 3, Elliptocytosis 3 |
| RS121918646 |
SPTB
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS121918647 |
SPTB
|
Health Risk |
Pathogenic |
Pyropoikilocytosis, hereditary |
| RS121918648 |
SPTB
|
Health Risk |
Pathogenic/Likely pathogenic |
Elliptocytosis 3, Hereditary spherocytosis type 2 |
| RS121918649 |
SPTB
|
Health Risk |
Conflicting classifications of pathogenicity |
ANEMIA, PERINATAL HEMOLYTIC |
| RS121918650 |
SPTB
|
Health Risk |
Pathogenic |
Elliptocytosis 3, Elliptocytosis 3 |
| RS121918651 |
SPTB
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spherocytosis type 2, Hereditary spherocytosis type 2 |
| RS121918652 |
SOX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Optic nerve hypoplasia and abnormalities of the central nervous system, Anophthalmia/microphthalmia-esophageal atresia syndrome |
| RS121918653 |
KITLG
|
Health Risk |
Pathogenic |
Hyperpigmentation with or without hypopigmentation, familial progressive |
| RS121918654 |
NR5A1
|
Health Risk |
Pathogenic |
46, XY sex reversal 3 |
| RS121918655 |
NR5A1
|
Health Risk |
Pathogenic |
46, XY sex reversal 3 |
| RS121918656 |
NR5A1
|
Health Risk |
Pathogenic |
46, XY sex reversal 3 |
| RS121918657 |
SURF1
|
Health Risk |
Pathogenic |
Mitochondrial complex IV deficiency, nuclear type 1 |
| RS121918658 |
SURF1
|
Health Risk |
Pathogenic |
Mitochondrial complex IV deficiency, nuclear type 1 |
| RS121918659 |
CD3E
|
Health Risk |
Pathogenic |
Immunodeficiency 18, Immunodeficiency 18 |
| RS121918660 |
CD8A
|
Health Risk |
Pathogenic |
Susceptibility to respiratory infections associated with CD8alpha chain mutation, Susceptibility to respiratory infections associated with CD8alpha chain mutation |